Lead Exposure in Newly Resettled Pediatric Refugees in Syracuse, NY

Christina D Lupone1,2, Danielle Daniels3, Dawn Lammert4

  • 1Department of Public Health & Preventive Medicine, SUNY Upstate Medical University, 750 East Adams Street, Syracuse, NY, 13210, USA. LuponeC@upstate.edu.

Insights

Refugee children face significant lead exposure risks post-resettlement. New exposures occurred in 8.3% of cases, highlighting the need for improved primary prevention strategies for all children.

Area of Science:

  • Environmental Health
  • Pediatric Public Health
  • Toxicology

Background:

  • Lead is a pervasive environmental toxin with severe health implications for children.
  • Refugee children are particularly vulnerable to lead poisoning due to post-resettlement factors like urban housing and environmental inequities.
  • Lack of funding, legislation, and advocacy exacerbate these risks.

Purpose of the Study:

  • To assess lead exposure in newly arrived and resettled refugee children.
  • To identify the prevalence of elevated blood lead levels (BLLs) upon arrival and post-resettlement.
  • To analyze new lead exposures and evaluate the effectiveness of current screening practices.

Main Methods:

  • A cohort of 705 refugee children (age 0-16 years) attending a university clinic in Syracuse, NY, was studied.
  • Blood lead levels (BLLs) were measured upon arrival and during follow-up visits.
  • Data were analyzed to determine the prevalence of elevated BLLs and identify new exposure sources.

Main Results:

  • 17% of newly arrived refugee children had elevated BLLs (≥5 µg/dL).
  • 10% had elevated BLLs upon follow-up, with 8.3% representing new exposures.
  • 30% showed increased BLLs at follow-up regardless of arrival status; many new exposures occurred in children over 2 years old, potentially missed by routine screening.

Conclusions:

  • Lead exposure remains a significant concern for refugee children, both upon arrival and after resettlement.
  • Current screening protocols may miss new lead exposures in older children, underscoring the need for enhanced primary prevention.
  • Targeted interventions are crucial to mitigate lead risks and improve health outcomes for all children, including resettled refugee populations.

Related Concept Videos

Phase-lead and Phase-lag Controllers01:22

Phase-lead and Phase-lag Controllers

Understanding the working function of different types of controllers can be illustrated with practical analogies, such as adjusting a stereo's volume equalizer. Cranking up the bass involves a phase-lead controller, which functions as a high-pass filter, while increasing the treble uses a phase-lag controller, which acts as a low-pass filter. PD controllers, similar to high-pass filters, enhance the system's response to high-frequency components. PI controllers, akin to low-pass...
539
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
225
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
285
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
212
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
271
Time and frequency -Domain Interpretation of Phase-lead Control01:24

Time and frequency -Domain Interpretation of Phase-lead Control

Phase-lead controllers are commonly used in various control systems to enhance response speed and stability. Adjusting the brightness on a television screen offers a practical example of phase-lead control. When contrast is enhanced, a phase-lead controller is employed. Mathematically, phase-lead control is identified when the first parameter is smaller than the second.
The design of phase-lead control involves the strategic placement of poles and zeros to balance steady-state error and system...
446